10-104380048-A-G
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_001008723.2(CFAP58):āc.1193A>Gā(p.Asn398Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000348 in 1,613,956 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
NM_001008723.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CFAP58 | NM_001008723.2 | c.1193A>G | p.Asn398Ser | missense_variant | 9/18 | ENST00000369704.8 | NP_001008723.1 | |
CFAP58 | NM_001400226.1 | c.1139A>G | p.Asn380Ser | missense_variant | 10/19 | NP_001387155.1 | ||
CFAP58 | NM_001400227.1 | c.1139A>G | p.Asn380Ser | missense_variant | 9/18 | NP_001387156.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CFAP58 | ENST00000369704.8 | c.1193A>G | p.Asn398Ser | missense_variant | 9/18 | 1 | NM_001008723.2 | ENSP00000358718 | P1 | |
CFAP58 | ENST00000369703.1 | c.59A>G | p.Asn20Ser | missense_variant | 2/3 | 2 | ENSP00000358717 |
Frequencies
GnomAD3 genomes AF: 0.000164 AC: 25AN: 152250Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000283 AC: 71AN: 250846Hom.: 0 AF XY: 0.000310 AC XY: 42AN XY: 135550
GnomAD4 exome AF: 0.000367 AC: 537AN: 1461706Hom.: 1 Cov.: 30 AF XY: 0.000355 AC XY: 258AN XY: 727158
GnomAD4 genome AF: 0.000164 AC: 25AN: 152250Hom.: 0 Cov.: 32 AF XY: 0.000242 AC XY: 18AN XY: 74382
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 29, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at